Letaplimab (IBI-188) is a human IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPalpha. Letaplimab enhances tumor cell phagocytosis[1].
Molecular Weight:
(142.38 kDa)
Purity:
95.00
CAS Number:
[2283356-07-8]
Target:
Others
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted